Eagle Pharmaceuticals, Inc. Obligations, Fair Value Disclosure
Eagle Pharmaceuticals, Inc. had Obligations, Fair Value Disclosure of $4.06 million as of 2022-12-31, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations · last filed 2023-08-09
- 2022-12-31: Obligations, Fair Value Disclosure $4.06M.
- 2022-09-30: Obligations, Fair Value Disclosure $4.06M.
- 2020-09-30: Obligations, Fair Value Disclosure $0.00.
- 2019-12-31: Obligations, Fair Value Disclosure $0.00.
| Period end | Obligations, Fair Value Disclosure |
|---|---|
| 2022-12-31 | $4.06M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $4.06M 10-Q · filed 2022-11-09 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-02 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-02 |